Cargando…

eGFR(cystatinC)/eGFR(creatinine) ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study

BACKGROUND: Shrunken Pore Syndrome (SPS), defined as a reduced ratio between two estimated filtration rates (based on cystatin C and creatinine) is an increasingly recognized risk factor for long-term mortality. Although some patients with other conditions might be erroneously identified as SPS. Our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avotins, Lauris, Kroica, Juta, Petersons, Aivars, Zentina, Dace, Kravale, Zaiga, Saulite, Anna, Racenis, Karlis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500727/ https://www.ncbi.nlm.nih.gov/pubmed/37704948 http://dx.doi.org/10.1186/s12882-023-03315-x

Ejemplares similares

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

S. aureus Colonization, Biofilm Production, and Phage Susceptibility in Peritoneal Dialysis Patients
por: Racenis, Karlis, et al.
Publicado: (2020)

Anti-Biofilm Effect of Bacteriophages and Antibiotics against Uropathogenic Escherichia coli
por: Mukane, Laima, et al.
Publicado: (2022)

Potential relationship between eGFR(cystatin C)/eGFR(creatinine)‐ratio and glomerular basement membrane thickness in diabetic kidney disease
por: Öberg, Carl M., et al.
Publicado: (2021)

Should Cystatin C eGFR Become Routine Clinical Practice?
por: Spencer, Sebastian, et al.
Publicado: (2023)

Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Femur Osteomyelitis—A Case Report
por: Racenis, Karlis, et al.
Publicado: (2022)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

Cystacin C-based eGFR and Creatinine Clearance-based eGFR in Patients with Severe Motor and Intellectual Disabilities
por: Tamura, Kouichi, et al.
Publicado: (2023)

Clinical Assessment of Follow-Up Cystatin C-Based eGFR in Live Kidney Donors
por: Han, Hyun Ho, et al.
Publicado: (2012)

Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia
por: Suzuki, Keita, et al.
Publicado: (2022)

Point of Care eGFR and the Prediction of Outcomes in Pneumonia
por: Suk, Chi-won, et al.
Publicado: (2019)

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care
por: Hirst, Jennifer A, et al.
Publicado: (2018)

International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE)
por: Caplin, Ben, et al.
Publicado: (2017)

Short‐Term Change in eGFR and Risk of Cardiovascular Events
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2014)

Age and the eGFR-dependent risk for adverse clinical outcomes
por: Liu, Ping, et al.
Publicado: (2022)

Pneumonia and hypercapnic respiratory failure
por: Ancans, Gusts, et al.
Publicado: (2019)

Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults
por: Werner, Karin, et al.
Publicado: (2018)

Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR
por: Hanna, Paul E., et al.
Publicado: (2023)

Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations
por: Eastwood, John B., et al.
Publicado: (2010)

Impaired selective renal filtration captured by eGFR(cysC)/eGFR(crea) ratio is associated with mortality in a population based cohort of older women
por: Malmgren, Linnea, et al.
Publicado: (2022)

Effect of the Biopolymer Carrier on Staphylococcus aureus Bacteriophage Lytic Activity
por: Stipniece, Liga, et al.
Publicado: (2022)

Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR
por: Munch, Philip Vestergaard, et al.
Publicado: (2023)

A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance
por: Mohd Tahir, Nor Asyikin, et al.
Publicado: (2020)

Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
por: Kusunoki, Hiroshi, et al.
Publicado: (2020)

The impact of automated eGFR reporting and education on nephrology service referrals
por: Noble, Euan, et al.
Publicado: (2008)

Renal quality outcomes framework and eGFR: impact on secondary care
por: Phillips, LA, et al.
Publicado: (2012)

Correlation analysis between eGFR(cys) and SXscore in patients with diabetes
por: YONG, ZHONG, et al.
Publicado: (2014)

Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment
por: Zammit, Andrea R., et al.
Publicado: (2015)

Mendelian Randomisation study of the influence of eGFR on coronary heart disease
por: Charoen, Pimphen, et al.
Publicado: (2016)

Decreased eGFR Is Associated With Ischemic Stroke in Patients With Dilated Cardiomyopathy
por: Deng, Yuqing, et al.
Publicado: (2019)

Combined Use of Serum Uromodulin and eGFR to Estimate Mortality Risk
por: Yazdani, Babak, et al.
Publicado: (2021)

Mild to moderate decrease in eGFR and cognitive decline in older adults
por: Grasing, Michael, et al.
Publicado: (2021)

Impact of low eGFR on the immune response against COVID-19
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2022)

Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study
por: Zhang, Ling, et al.
Publicado: (2022)

Interactions between the principal risk factors for reduction of the eGFR in unvaccinated COVID‑19 survivors: Normal pre-COVID‑19 eGFR, not having diabetes and being hospitalized
por: Guzman-Esquivel, Jose, et al.
Publicado: (2023)

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients
por: Popova, Anna, et al.
Publicado: (2022)

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
por: Böger, Carsten A., et al.
Publicado: (2011)

Age- and gender-adjusted eGFR to estimate baseline creatinine for RIFLE criteria
por: Spoorenberg, Simone M. C., et al.
Publicado: (2011)

Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy
por: Furuichi, Kengo, et al.
Publicado: (2020)

Eliminating Race From eGFR Calculations: Impact on Living Donor Programs
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r99rhqfpg0529uq6gat8nsmpkn